A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
The objective of this study is to compare the safety and efficacy of 0.25% HBM9036 (HL036) Ophthalmic Solution to placebo for the treatment of the Chinese subjects with moderate and severe dry eye.
Epistemonikos ID: 4093007e4fdfa6b5f18e40e9cbf17d9a1ee0a2fb
First added on: Mar 23, 2022